Understanding breast cancer heterogeneity through non-genetic heterogeneity Neda Barzgar BaroughFakhrosadat SajjadianKobra Velaei Review Article 15 March 2021 Pages: 777 - 791
Immune-related biomarkers in triple-negative breast cancer Juan ZhangQi TianJin Yang Review Article Open access 09 April 2021 Pages: 792 - 805
Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer Xuemin LiuQingyu ChangYikun Jiang Original Article Open access 21 January 2021 Pages: 806 - 821
Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 − negative subtype Yuko TanakaTakashi OhnoYoshihisa Umekita Original Article 22 January 2021 Pages: 822 - 828
Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p/ZNF367 pathway Lei DuXingguang TaoXiaowei Shen Original Article 26 March 2021 Pages: 829 - 837
Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer Tomohiro OchiHiroko TsunodaHideko Yamauchi Original Article 09 February 2021 Pages: 838 - 847
Adenosquamous carcinoma of the breast: a population-based study Cheng XuZhangyuan GuZhigang Zhuang Original Article Open access 12 February 2021 Pages: 848 - 858
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells Yingzi ZhangJiao TianShengchun Liu Original Article Open access 10 February 2021 Pages: 859 - 873
Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society Sungmin ParkJoon JeongSoo Youn Bae Original Article 14 February 2021 Pages: 874 - 883
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin Xiaozhong TengTetsu HayashidaYuko Kitagawa Original Article 22 February 2021 Pages: 884 - 895
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study Kiyo TanakaNorikazu MasudaHiroji Iwata Original Article Open access 18 February 2021 Pages: 896 - 903
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer Hajime KurodaTsengelmaa JamiyanAtsuko Masunaga Original Article Open access 25 February 2021 Pages: 904 - 914
Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases Hiroyuki MinemuraKiyoshi TakagiTakashi Suzuki Original Article 12 March 2021 Pages: 915 - 926
Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast Mitsuhiro TozakiHidetake YabuuchiHiroshi Nakahara Original Article 24 February 2021 Pages: 927 - 936
Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population Azin NahvijouHossein SafariHosein Ameri Original Article 05 March 2021 Pages: 937 - 943
Correction to: Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population Azin NahvijouHossein SafariHosein Ameri Correction 26 March 2021 Pages: 944 - 944
Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan Masato TakahashiKenichi InoueJunji Tsurutani Original Article Open access 07 March 2021 Pages: 945 - 955
Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio Vincent Vinh-HungHendrik EveraertMark De Ridder Original Article 10 March 2021 Pages: 956 - 968
Practical approach to prevent COVID-19 infection at breast cancer screening Mamoru TakadaGaku TanakaFumio Imazeki Original Article Open access 02 April 2021 Pages: 969 - 976
Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancer Ako OharaYasuto NaoiShinzaburo Noguchi Rapid Communication 16 February 2021 Pages: 977 - 982
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition Takayoshi UematsuKazutaka NakashimaHiroji Iwata Correction Open access 19 May 2021 Pages: 983 - 984
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition Tatsunori ShimoiShigenori E. NagaiTatsuya Toyama Correction Open access 22 April 2021 Pages: 985 - 986
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient Hiroji IwataShigehira SajiChikako Yamauchi Correction Open access 19 May 2021 Pages: 987 - 987
Correction to: The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition Chikako YamauchiMichio YoshimuraHiroji Iwata Correction Open access 19 May 2021 Pages: 988 - 988
Correction to: The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition Masafumi InokuchiGoro KutomiHiroji Iwata Correction Open access 19 May 2021 Pages: 989 - 989